[1] |
LIU Lijing, QIAN Hong, MENG Qingxin, ZHANG Xiang, HE Bin, HE Jianbin, WEI Yingmin.
Sinomenine inhibits oxidative stress and pulmonary fibrosis by activating the Keap1/Nrf2 signaling pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 979-987.
|
[2] |
LI Yating, YUE Hongmei, LIU Miaomiao, XU Jinhui, WU Xingdong, ZHU Haobin.
The possibility of phosphodiesterase 4 inhibitors as drug therapy for idiopathic pulmonary fibrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 818-823.
|
[3] |
LIU Nanyu, YUE Hongmei, SONG Peipei, WEI Jifang, WEI Yaqian, XIE Yingying, WANG Jiaqi .
PDE4 inhibitors serve as therapeutic targets for pulmonary fibrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(3): 355-360.
|
[4] |
WANG Jie, LI Long, CHEN Feng, LIU Shengfei.
Research progress of metformin in the pathogenesis of pulmonary fibrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 235-240.
|
[5] |
LIU Nanyu, YUE Hongmei, SONG Peipei, WEI Jifang, WEI Yaqian, XIE Yingying, WANG Jiaqi.
Integrins targeting αv are used as drug targets for pulmonary fibrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(6): 709-714.
|
[6] |
LI Xueheng, LI Long.
Research progress on the relationship between melatonin and idiopathic pulmonary fibrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(6): 715-720.
|
[7] |
WEI Jifang, YUE Hongmei, LIU Nanyu, SONG Peipei, XIE Yingying, WANG Jiaqi, WEI Yaqian.
Research progress on the relationship between thyroid hormone and idiopathic pulmonary fibrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(3): 307-313.
|
[8] |
ZHOU Shiqin, LUO Yali, ZHOU Wen, Qi Xiaofeng, XIAO Mengyong.
Molecular mechanism and treatment of pulmonary fibrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(10): 1133-1147.
|
[9] |
HAO Wei, ZUO Dongze, ZHANG Junxiu, JIANG Lili, XIONG Ying, YANG Jieren.
Effects of metformin on epithelial-mesenchymal transition of rat alveolar epithelial type II cells induced by TGF-β1
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(7): 744-752.
|
[10] |
MA Yuandong, HUANG Zuwei, AN Pei, XIE Xiaofei, LIU Xiaocai, MAO Lingzhe.
Effects of ambroxol hydrochloride on pulmonary fibrosis in rats and its effect on TGF-β/Smad/ERK signal transduction pathway and Th17/Treg cell imbalance
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(11): 1201-1208.
|
[11] |
XU Hong-lei, JIN Xu-ru, CHEN Shao-xian.
Inhibitory effects and mechanisms of tranilast on pulmonary fibrosis in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(7): 754-759.
|
[12] |
TAO Hong, CHEN Li-xin, CEN Ming, LIN Jiang.
Effects of adenoviral vector mediated Fas ligand gene introduction on the medial layers of vascular smooth muscle cell density after rat carotid artery injury
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2008, 13(12): 1401-1403.
|
[13] |
LI Na, WANG Qiu-juan, DAI De-zai, HE Hai-bo, FENG Yu, DAI Yin.
Endothelin receptor antagonist CPU0213 improves pulmonary injury and fibrosis induced by bleomycin and oleic acid in mice
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2007, 12(9): 998-1003.
|
[14] |
FU Song-quan, FU Song-bo, YAN Xi-lin, LIU Zhen-fen, RAN Jun–tao, ZHAO Chong-chong.
Protecting effect of matrine on pulmonary interstitial fibrosis in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2007, 12(12): 1376-1380.
|
[15] |
YE Jin-yan, XIE Yu-peng, MAO Sun-zhong, FANG Zhou-xi, CHEN Shao-xian.
Effects of dexameathone on pulmonary fibrosis induced by bleomycin and oxygen-derived free radicals in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(4): 397-400.
|